Socio‐economic position and the prevalence of ten chronic diseases in Australia, 2021: a whole of population census data analysis
The prevalence of chronic disease differs by socio-economic position, but the direction, magnitude, and consistency of the effect differs by disease, socio-economic position measure, age, and sex. Understanding the relationship between different socio-economic position measures and chronic diseases facilitates the formulation of directed interventions.
Authors
- Agus Salim (ORCID: https://orcid.org/0000-0003-3999-7701)
- Spiros Fourlanos (ORCID: https://orcid.org/0000-0002-5153-8324)
- Joanna Y. Gong (ORCID: https://orcid.org/0000-0002-0702-5740)
- Jonathan E. Shaw (ORCID: https://orcid.org/0000-0002-6187-2203)
- Emily D. Williams (ORCID: https://orcid.org/0000-0002-9399-1960)
- Dianna J. Magliano (ORCID: https://orcid.org/0000-0002-6026-5065)
Institutions
- The Royal Melbourne Hospital (AU)
- Baker Heart and Diabetes Institute (AU)
- The University of Melbourne (AU)
- King's College London (GB)
- La Trobe University (AU)
- Western Health (AU)
- Monash University (AU)
Publication Details
- Journal
- The Medical Journal of Australia
- Published
- 2025-08-19
- DOI
- https://doi.org/10.5694/mja2.70032
- Citations
- 1
- Primary Topic
- Health disparities and outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.17
Funders
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Mylan
- National Heart Foundation of Australia
- University of Melbourne
- Novo Nordisk
- Medical Research Council
- National Health and Medical Research Council